Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: erratum to the Evidence Review Group report Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: erratum Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: post-Appraisal Committee meeting erratum This page was last updated: 21 January 2013